BIO:NYSE
Bio-Rad Laboratories, Inc. Class A Common Stock
$364.42
arrow_downward
-0.48%(-1.74) 1D
$364.42
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 12, 4:00:06 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BIO...
Open
$369.85
High
$369.85
Low
$359.41
Mkt. cap
9.74B
Avg. vol.
259.89K
Volume
181.20K
P/E ratio
44.18
52-wk high
$396.23
52-wk low
$236.73
EPS
$8.25
Beta
1.07
Shares outstanding
21.68M
No. of employees
7K
Open
$369.85
High
$369.85
Low
$359.41
Mkt. cap
9.74B
Avg. vol.
259.89K
Volume
181.20K
P/E ratio
44.18
52-wk high
$396.23
52-wk low
$236.73
EPS
$8.25
Beta
1.07
Shares outstanding
21.68M
No. of employees
7K
News stories
From web sources and news partners
https://www.dars.gov.et/
·
3 days ago
BIO Q2 2026 Earnings: EPS Tops Consensus by 48% as Shares Edge Higher - Estimate Accuracy
Profile
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California, by husband and wife team David and Alice Schwartz, both graduates of the University of California, Berkeley. Bio-Rad is based in Hercules, California, and has operations worldwide. Wikipedia
About Bio-Rad Laboratories, Inc. Class A Common Stock
CEONorman David Schwartz
Employees7.45K
Founded1952
HeadquartersHercules, California, United States
SectorHealth care
Websitebio-rad.com